Literature DB >> 7896880

The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2.

T Yang1, K M Kozopas, R W Craig.   

Abstract

A family of genes related to the bcl-2 protooncogene has recently emerged. One member of this family, mcl-1, was cloned from a human myeloblastic leukemia cell line (ML-1) undergoing differentiation. The intracellular localization of mcl-1, as well as the kinetics of its expression during differentiation, have now been studied. These studies show that the intracellular distribution of mcl-1 overlaps with, but is not identical to, that of bcl-2: mcl-1 is similar to bcl-2 in that the mcl-1 protein has a prominent mitochondrial localization, and in that it associates with membranes through its carboxyl hydrophobic tail. mcl-1 differs from bcl-2, however, in its relative distribution among other (nonmitochondrial/heavy membrane) compartments, mcl-1 also being abundant in the light membrane fraction of immature ML-1 cells while bcl-2 is abundant in the nuclear fraction. Similarly, in differentiating ML-1 cells, the timing of expression of mcl-1 overlaps with, but is not identical to, that of bcl-2: the mcl-1 protein increases rapidly as cells initiate differentiation, and mcl-1 is a labile protein. In contrast, bcl-2 decreases gradually as cells complete differentiation. Overall, the mcl-1 and bcl-2 proteins have some properties in common and others tht are distinct. A burst of expression of mcl-1, prominently associated with mitochondria, complements the continued expression of bcl-2 in ML-1 cells differentiating along the monocyte/macrophage pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7896880      PMCID: PMC2120408          DOI: 10.1083/jcb.128.6.1173

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  55 in total

1.  bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair.

Authors:  S Kamesaki; H Kamesaki; T J Jorgensen; A Tanizawa; Y Pommier; J Cossman
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

2.  Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells.

Authors:  R W Craig; H L Buchan; C I Civin; M B Kastan
Journal:  Cell Growth Differ       Date:  1993-05

3.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

Authors:  Z N Oltvai; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

4.  bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.

Authors:  J Gratiot-Deans; L Ding; L A Turka; G Nuñez
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

5.  Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2 beta protein restores function as a regulator of cell survival.

Authors:  S Tanaka; K Saito; J C Reed
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

6.  Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes.

Authors:  D J Veis; C L Sentman; E A Bach; S J Korsmeyer
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

7.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

8.  Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2.

Authors:  E Y Lin; A Orlofsky; M S Berger; M B Prystowsky
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

9.  Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice.

Authors:  K Nakayama; K Nakayama; I Negishi; K Kuida; Y Shinkai; M C Louie; L E Fields; P J Lucas; V Stewart; F W Alt
Journal:  Science       Date:  1993-09-17       Impact factor: 47.728

10.  bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria.

Authors:  M González-García; R Pérez-Ballestero; L Ding; L Duan; L H Boise; C B Thompson; G Núñez
Journal:  Development       Date:  1994-10       Impact factor: 6.868

View more
  88 in total

1.  Activation of membrane-associated procaspase-3 is regulated by Bcl-2.

Authors:  J F Krebs; R C Armstrong; A Srinivasan; T Aja; A M Wong; A Aboy; R Sayers; B Pham; T Vu; K Hoang; D S Karanewsky; C Leist; A Schmitz; J C Wu; K J Tomaselli; L C Fritz
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

Review 2.  Endoplasmic reticulum stress: cell life and death decisions.

Authors:  Chunyan Xu; Beatrice Bailly-Maitre; John C Reed
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  An internal EELD domain facilitates mitochondrial targeting of Mcl-1 via a Tom70-dependent pathway.

Authors:  Chiang-Hung Chou; Ru-Shuo Lee; Hsin-Fang Yang-Yen
Journal:  Mol Biol Cell       Date:  2006-07-05       Impact factor: 4.138

4.  Rapid turnover of mcl-1 couples translation to cell survival and apoptosis.

Authors:  Kenneth W Adams; Geoffrey M Cooper
Journal:  J Biol Chem       Date:  2007-01-02       Impact factor: 5.157

5.  Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.

Authors:  Rong Chen; Lei Guo; Yuling Chen; Yingjun Jiang; William G Wierda; William Plunkett
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

6.  Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer.

Authors:  Qingqing Ding; Longfei Huo; Jer-Yen Yang; Weiya Xia; Yongkun Wei; Yong Liao; Chun-Ju Chang; Yan Yang; Chien-Chen Lai; Dung-Fang Lee; Chia-Jui Yen; Yun-Ju Rita Chen; Jung-Mao Hsu; Hsu-Ping Kuo; Chun-Yi Lin; Fuu-Jen Tsai; Long-Yuan Li; Chang-Hai Tsai; Mien-Chie Hung
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

7.  Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP.

Authors:  Kumudha Balakrishnan; Christine M Stellrecht; Davide Genini; Mary Ayres; William G Wierda; Michael J Keating; Lorenzo M Leoni; Varsha Gandhi
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

8.  Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells.

Authors:  Shanna K Nifoussi; Nora R Ratcliffe; Deborah L Ornstein; Gary Kasof; Stefan Strack; Ruth W Craig
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

9.  ELP-dependent expression of MCL1 promotes resistance to EGFR inhibition in triple-negative breast cancer cells.

Authors:  Peter Cruz-Gordillo; Megan E Honeywell; Nicholas W Harper; Thomas Leete; Michael J Lee
Journal:  Sci Signal       Date:  2020-11-17       Impact factor: 8.192

10.  Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis.

Authors:  D G Tang; Y Q Chen; K V Honn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.